AVEO Pharmaceuticals Inc

NASDAQ:AVEO   2:04:24 PM EDT
14.90
+0.01 (+0.07%)
Earnings Announcements

Aveo Oncology Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:46 GMT
AVEO Pharmaceuticals Inc (AVEO) - Aveo Oncology Reports Third Quarter 2022 Financial Results.
Q3 of 2022 Total Revenue Approximately $30.4 Million Versus $15.2 Million Q3 of 2021.
Q3 Loss per Share $0.09.
Q3 Earnings per Share View $-0.18, Revenue View $29.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $34.78 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $35 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.